EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases

Giselle de Souza Carvalho, Lucas Delmonico, Gilda Alves, Maria Helena Ornellas, Fabiana Resende Rodrigues, Priscila Valverde Fernandes, Isabele Ávila Small, Jessé Lopes da Silva, Luiz Henrique Lima Araujo

Cancer Treatment and Research Communications · 2026

DOI: 10.1016/j.ctarc.2026.101284 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Giselle de Souza Carvalho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research and Technological Development Division, Brazilian National Cancer Institute (INCA), Rio de Janeiro/RJ, Brazil. Electronic address: …. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms, High-Throughput Nucleotide Sequencing, Biomarkers, Tumor. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Breast cancer (BC) is a heterogeneous disease, and its molecular and immunohistochemical (IHC) profiles may change over time, particularly under therapeutic pressure. IHC discordance between primary tumors and BC brain metastases (BCBM) has been reported, yet its biological and clinical significance remains incompletely defined. Genomic profiling using next-generation sequencing (NGS) may provide additional insight into tumor evolution and clonal selection, although data from paired BC and BCBM are limited. METHODS: This translational case series included six patients randomly selected from an institutional cohort of BC patients who underwent neurosurgical resection of BCBM. IHC reassessment (ER, PR, and HER2) and NGS profiling using targeted panels were performed. RESULTS: Three of the six cases presented with IHC discordance, mainly loss of HR expression and gain of HER2 in BCBM. Genomic profiling identified 23 mutations in primary tumors compared with four in BCBM. BRCA1/2 variants predominated in primary tumors (21/23, 91%), most predicted to result in loss-of-function alterations. One mutation (PIK3CA/N345K) was shared between primary and metastatic tissues within the same patient. Overall survival ranged from 28 to 146 months. CONCLUSION: This paired analysis demonstrates immunophenotypic and genomic divergence between BC and BCBM, supporting the concept of dynamic tumor evolution. Receptor conversion and emergence or loss of actionable genomic alterations highlight the potential value of repeat molecular assessment in advanced stages. Although limited by a small sample size, retrospective design, and absence of matched germline testing, these findings reinforce the importance of integrating biomarker reevaluation into the management of selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBrain NeoplasmsHigh-Throughput Nucleotide SequencingBiomarkers, TumorHumansFemaleMiddle AgedAdultMutationErb-b2 Receptor Tyrosine KinasesAged

Stichwörter der Autor:innen

Brain metastasesBreast cancerNext-generation sequencingTumor heterogeneity

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Clinical Research and Technological Development Division, Brazilian National Cancer Institute (INCA), Rio de Janeiro/RJ, Brazil. Electronic address: giselle.medicinauerj@gmail.com.
  • General Pathology Department, State University of Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
  • Pathology Department, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.
  • Clinical Research and Technological Development Division, Brazilian National Cancer Institute (INCA), Rio de Janeiro/RJ, Brazil.

Zitieren

APA

de Souza Carvalho, G., Delmonico, L., Alves, G., Ornellas, M. H., Rodrigues, F. R., Fernandes, P. V., Small, I. Á., da Silva, J. L., & Araujo, L. H. L. (2026). Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101284

Vancouver

de Souza Carvalho G, Delmonico L, Alves G, Ornellas MH, Rodrigues FR, Fernandes PV, et al. Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101284

BibTeX
@article{deSouzaCarvalho2026,
  author = {de Souza Carvalho, Giselle and Delmonico, Lucas and Alves, Gilda and Ornellas, Maria Helena and Rodrigues, Fabiana Resende and Fernandes, Priscila Valverde and Small, Isabele Ávila and da Silva, Jessé Lopes and Araujo, Luiz Henrique Lima},
  title = {Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  doi = {10.1016/j.ctarc.2026.101284}
}
Kostenlos starten →